The Cancer Letter

The leading source for information on the issues that shape oncology since 1973

In the Archives

The National Cancer Act 20 years later: impact as seen by its architects in 1991

Share on facebook
Share on twitter
Share on linkedin
Share on email
Share on print
BYLINE
IN THIS ISSUE
DOWNLOAD PDFTABLE OF CONTENTS

The Impact of The National Cancer Act. 1971-1991. Statements. December 18, 1991.By National Cancer Institute | Feb. 24, 2021

In 1991, NCI recorded impact statements commemorating the twentieth anniversary of the National Cancer Act of 1971—and now this historic document has been digitized and made searchable in the Cancer History Project.

Statements from architects of the National Cancer Act, leaders of NCI, advisors to the institute, and prominent oncologists demonstrate how the field had progressed in the first two decades—from 1971 to 1991.

To access this subscriber-only content please log in or subscribe.

If your institution has a site license, log in with IP-login or register for a sponsored account.*
*Not all site licenses are enrolled in sponsored accounts.

Login Subscribe
Table of Contents

YOU MAY BE INTERESTED IN

Regulatory News

Makary vows to speed up drug approvals and end FDA’s “cozy” relationship with industry
Commissioner promises to protect scientific integrity while bringing in “fresh” MAHA ideas

In his first sit-down interview since beginning his role as FDA commissioner 17 days earlier, Marty Makary, a former Johns Hopkins surgeon and the only Trump pick for HHS whose confirmation received Democratic support, said he would speed up approvals for rare-disease treatments by reducing reliance on animal testing and shifting towards organoids and computational models. 
By Claire Marie Porter
Table of Contents

Never miss an issue!

Get alerts for our award-winning coverage in your inbox.

Login

Site license subscribers:
Log in with your IP | Register a sponsored account